TP53 Mutant Variant Allele Frequency and Cytogenetics Determine Prognostic Groups in MDS/AML for Transplantation.
Lontos K, Saliba RM, Kanagal-Shamanna R, Ozcan G, Ramdial JL, Chen GL, Kadia TM, Short NJ, Daver NG, Kantarjian HM, Marin D, Kebriaei P, Popat UR, Champlin RE, Shpall EJ, Oran B.
Lontos K, et al. Among authors: chen gl.
Blood Adv. 2025 Jan 24:bloodadvances.2024014499. doi: 10.1182/bloodadvances.2024014499. Online ahead of print.
Blood Adv. 2025.
PMID: 39853269